# Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13

> **NCT00000348** · PHASE1 · UNKNOWN · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Cocaine-Related Disorders

## Interventions

- **DRUG:** Dihydrexidine

## Key facts

- **NCT ID:** NCT00000348
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000348, "Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00000348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*